Lucid Diagnostics Inc. Common Stock (LUCD) Stock Price

LUCDStock

$0.48−61.14%52W

Market Cap$91.27M

P/E—

PEG Ratio—

Div yield—

Beta1.19

LUCD Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-74.50%

Price vs S&P 500 (4W)-42.11%

VGM Score34.98

Book Value / Share (Quarterly)$0.06

P/TBV (Annual)13.45x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)131.36%

Cash Flow / Share (Quarterly)$-0.25

Price vs S&P 500 (YTD)-68.07%

Gross Margin (TTM)-21.71%

Net Profit Margin (TTM)-959.76%

EPS (TTM)$-0.38

10-Day Avg Trading Volume1.94M

EPS Excl Extra (TTM)$-0.38

EPS (Annual)$-0.57

ROI (Annual)-166.05%

Gross Margin (Annual)-41.73%

Net Profit Margin (5Y Avg)-4969.40%

Cash / Share (Quarterly)$0.18

Revenue Growth QoQ (YoY)26.74%

ROA (Last FY)-143.43%

Revenue Growth TTM (YoY)24.89%

EBITD / Share (TTM)$-0.36

Operating Margin (TTM)-950.65%

Cash Flow / Share (Annual)$-0.36

P/B Ratio8.89x

P/B Ratio (Quarterly)18.68x

Net Income / Employee (Annual)$-707,400

EV / Revenue (TTM)16.02x

Net Interest Coverage (TTM)-41.55x

ROA (TTM)-125.42%

EPS Incl Extra (Annual)$-0.57

Current Ratio (Annual)1.31x

Quick Ratio (Quarterly)1.29x

3-Month Avg Trading Volume1.51M

52-Week Price Return-61.14%

Revenue / Employee (TTM)$66,400

Tangible BV / Share (Quarterly)$0.06

P/S Ratio (Annual)20.64x

Asset Turnover (Annual)0.12x

52-Week High$1.63

Operating Margin (5Y Avg)-4903.94%

EPS Excl Extra (Annual)$-0.57

26-Week Price Return-64.59%

Quick Ratio (Annual)1.27x

13-Week Price Return-49.69%

Total Debt / Equity (Annual)2.19x

Current Ratio (Quarterly)1.33x

Enterprise Value$87.25M

Asset Turnover (TTM)0.13x

Revenue / Employee (Annual)$57,400

Pretax Margin (Annual)-1232.68%

Cash / Share (Annual)$0.26

3-Month Return Std Dev68.08%

Gross Margin (5Y Avg)-224.39%

Net Income / Employee (TTM)$-637,300

ROE (Last FY)-530.45%

Net Interest Coverage (Annual)-212.25x

EPS Basic Excl Extra (Annual)$-0.57

Receivables Turnover (TTM)7.45x

Total Debt / Equity (Quarterly)2.15x

EPS Incl Extra (TTM)$-0.38

Receivables Turnover (Annual)13.68x

ROI (TTM)-142.49%

P/S Ratio (TTM)17.84x

Pretax Margin (5Y Avg)-4969.40%

Revenue / Share (Annual)$0.05

Tangible BV / Share (Annual)$0.08

Price vs S&P 500 (52W)-76.67%

Year-to-Date Return-56.15%

5-Day Price Return-19.99%

EPS Normalized (Annual)$-0.57

ROA (5Y Avg)-141.03%

Net Profit Margin (Annual)-1232.68%

Month-to-Date Return-36.35%

Cash Flow / Share (TTM)$-1.34

EBITD / Share (Annual)$-0.49

Operating Margin (Annual)-1077.73%

EPS Basic Excl Extra (TTM)$-0.38

P/TBV (Quarterly)18.86x

P/B Ratio (Annual)13.07x

Inventory Turnover (TTM)13.40x

Pretax Margin (TTM)-959.76%

Book Value / Share (Annual)$0.08

Price vs S&P 500 (13W)-52.38%

Beta1.19x

Revenue / Share (TTM)$0.03

ROE (TTM)-404.34%

52-Week Low$0.47

vGradeF

gGradeB

mGradeF

vgmGradeD

LUCD Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 13, 2026	-$0.06	-$0.06	-9.09%(-$0.01)
Q1 2026	May 14, 2026	-$0.06	-$0.07	-10.53%(-$0.01)
Q4 2025	Mar 26, 2026	-$0.09	-$0.10	-15.38%(-$0.01)
Q3 2025	Nov 12, 2025	-$0.09	-$0.10	-15.38%(-$0.01)
Q2 2025	Aug 13, 2025	-$0.10	-$0.10	+0.00%(+$0.00)

LUCD Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

4.18

Industry Peers — Surgical & Medical Instruments(142)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth (5Y)	Gross Margin (TTM)	Operating Margin (TTM)	Price
LUCDLucid Diagnostics Inc. Common Stock	F	B	F	17.8x	—	-21.7%	-950.6%	$0.48
SYKStryker Corporation	C	B	C	4.4x	11.8%	65.3%	21.3%	$294.66
MMM3M Company	C	D	B	3.4x	-5.0%	39.4%	18.4%	$164.75
BSXBoston Scientific Corp.	C	B	C	3.1x	15.2%	69.5%	19.8%	$44.39
BDXBecton, Dickinson and Co.	B	D	A	2.5x	6.3%	46.7%	9.6%	$191.75
MDLNMedline Inc. Class A common stock	C	D	C	1.6x	—	26.2%	6.0%	$35.96
RMDResMed Inc.	C	C	B	5.9x	12.1%	61.1%	33.4%	$238.97
DXCMDexCom, Inc.	C	B	B	6.5x	19.3%	64.3%	22.9%	$86.04
WSTWest Pharmaceutical Services, Inc.	D	C	A	8.5x	7.4%	36.8%	20.4%	$384.02
SOLVSolventum Corporation	C	C	B	1.8x	—	54.8%	23.9%	$85.81
BAXBaxter International Inc.	B	D	B	1.1x	-0.8%	30.7%	-2.3%	$25.28
PENPenumbra, Inc.	F	C	B	8.4x	20.2%	67.8%	12.4%	$320.86
GMEDGLOBUS MEDICAL INC	B	B	B	3.3x	30.1%	68.5%	20.6%	$76.71
PODDInsulet Corporation	C	A	C	3.2x	24.5%	71.1%	16.9%	$141.10
GKOSGlaukos Corporation	F	A	B	15.9x	17.7%	79.1%	-31.6%	$164.84
TFXTeleflex Incorporated	B	F	B	2.1x	-4.7%	53.8%	-11.7%	$130.43
HAEHaemonetics Corporation	C	C	A	4.0x	8.9%	59.1%	11.9%	$118.28
MMSIMerit Medical Systems Inc	C	B	B	3.4x	9.5%	49.5%	12.8%	$89.20
STVNStevanato Group S.p.A.	D	C	C	3.7x	12.4%	29.9%	16.4%	$18.90
MMEDMiniMed Group, Inc. Common Stock	—	—	B	—	—	—	—	$17.49
HTFLHeartflow, Inc. Common Stock	F	A	A	19.8x	—	80.1%	-40.8%	$48.29
ICUIICU Medical Inc	C	D	B	1.9x	11.9%	39.1%	3.5%	$162.99
IRTCiRhythm Holdings, Inc. Common Stock	D	B	C	4.3x	23.0%	71.5%	-3.0%	$108.66
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	2725.9x	—	0.3%	-7007.8%	$44.43
ATRCAtriCure, Inc.	D	B	A	5.0x	20.9%	76.3%	2.3%	$56.07
UFPTUFP Technologies Inc	C	B	A	3.6x	27.4%	28.5%	15.3%	$291.67
INSPInspire Medical Systems, Inc.	B	B	B	2.2x	51.2%	86.1%	6.0%	$68.79
LMATLeMaitre Vascular, Inc.	C	B	C	7.0x	14.0%	72.9%	29.5%	$80.82
NVCRNovoCure Limited Ordinary Shares	D	C	C	2.3x	5.8%	76.1%	-22.1%	$14.07
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	15.2x	—	53.9%	-140.4%	$27.24
ATECAlphatec Holdings, Inc.	D	B	C	2.0x	39.5%	70.8%	-7.5%	$10.46
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	B	—	—	—	—	$12.29
TNDMTandem Diabetes Care, Inc.	D	C	C	1.1x	15.3%	56.0%	-4.4%	$16.24
IRMDiRadimed Corporation	D	B	B	13.1x	21.4%	75.9%	31.9%	$88.27
AORTArtivion, Inc.	C	C	C	2.3x	11.8%	64.4%	2.9%	$21.78
IARTIntegra LifeSciences Holdings	B	F	C	0.6x	3.6%	57.2%	4.0%	$13.21
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	3.0x	109.0%	64.2%	-33.9%	$17.57
BVSBioventus Inc. Class A Common Stock	B	C	A	1.9x	12.1%	68.7%	10.0%	$13.30
BBNXBeta Bionics, Inc. Common Stock	D	A	C	7.4x	—	58.3%	-69.8%	$16.35
SIBNSI-BONE, Inc. Common Stock	D	B	B	4.1x	22.3%	79.5%	-8.3%	$19.68
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	—	—	—	—	$24.00
MDXGMiMedx Group, Inc	C	D	C	1.8x	11.0%	78.8%	2.5%	$4.43
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	2.3x	27.2%	73.7%	-11.9%	$21.95
TCMDTactile Systems Technology, Inc.	B	B	B	1.5x	12.0%	51.9%	10.0%	$22.52
SSIISS Innovations International Inc. Common Stock	F	A	D	9.7x	—	47.6%	-16.2%	$2.53
DCTHDelcath Systems Inc	D	C	B	5.1x	120.1%	87.0%	-1.9%	$14.08
ANGOAngioDynamics, Inc.	C	D	C	1.5x	1.9%	55.6%	-11.2%	$11.24
BWAYBrainsway Ltd. American Depositary Shares	D	B	B	9.5x	12.2%	74.9%	5.8%	$11.44
SGHTSight Sciences, Inc. Common Stock	D	B	A	5.5x	22.9%	88.4%	-33.4%	$8.28
CERSCerus Corp	D	C	C	1.8x	15.4%	57.2%	-0.7%	$2.18
NPCENeuropace, Inc. Common Stock	D	C	C	4.3x	19.4%	79.6%	-15.3%	$12.24

About Lucid Diagnostics Inc. Common Stock

Lucid Diagnostics is a commercial-stage company developing diagnostic tools for patients with gastroesophageal reflux disease (GERD) at risk of esophageal cancer. Its products, EsoCheck and EsoGuard, enable detection of precancerous changes in the esophagus, addressing an unmet clinical need in cancer prevention. The company targets a significant market opportunity among millions of GERD patients vulnerable to esophageal adenocarcinoma.

LUCD Next Earnings Report

Report dateNov 11, 2026

QuarterQ3 2026

Report timeBMO

EPS estimate-$0.06

Revenue estimate$1.64M

Also reporting on Nov 11, 2026

Scheduled date with consensus estimates — both can change before the company reports.

Earnings calendar for November 2026

Companies in Related Industries

STXSStereotaxis, Inc. Common StockElectromedical Equipment
VANIVivani Medical, Inc. Common Stock (DE)Electromedical Equipment
NRXSNeuraxis, Inc.Electromedical Equipment
KEQUKewaunee Scientific CorpLab Apparatus & Furniture
LAKELakeland Industries IncOrthopedic & Prosthetic Devices
CNXUConexeu Sciences Inc. Common StockOrthopedic & Prosthetic Devices
STEXStreamex Corp. Common StockElectromedical Equipment
HYPRHyperfine, Inc. Class A Common StockElectromedical Equipment

Same SIC sector, outside this company's own industry.

Analyst Sentiment

4.2

Buy

Consensus rating

52-Week Range

Low$0.47

High$1.63